Can Immunoexpression of Cancer Stem Cell Markers Prognosticate Tongue Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis

Abstract

The objective was to evaluate the association of the immunoexpression of cancer stem cell (CSC) markers with clinicopathological and survival outcomes in tongue squamous cell carcinoma (TSCC) patients. This systematic review and meta-analysis [PROSPERO (CRD42021226791)] included observational studies that compared the association of clinicopathological and survival outcomes with CSC immunoexpression in TSCC patients. Pooled odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CI) were used as outcome measures. Six studies identified the association with three surface markers (c-MET, STAT3, CD44) and four transcription markers (NANOG, OCT4, BMI, SOX2). The odds of early-stage presentation were 41% (OR = 0.59, 95% CI 0.42–0.83) and 75% (OR = 0.25; 95% CI 0.14–0.45) lower in CSC and SOX2 immuno-positive cases than immuno-negative cases, respectively. The odds of well-differentiated tumors in transcription marker immuno-positive cases were 45% lower compared to immuno-negative cases (OR = 0.55, 95% CI 0.32–0.96). The odds of positive lymph nodes were 2.01 times higher in CSC immuno-positive cases compared to immuno-negative cases (OR = 2.01, 95% CI 1.11–3.65). Mortality in immuno-positive cases was 121% higher than that in immuno-negative cases (HR = 2.21; 95% CI 1.16–4.21). Advanced tumor staging and grading, lymph node metastasis, and mortality were significantly associated with positive immunoexpression of CSC markers.

Prognostic significance of lactate dehydrogenase and its impact on the outcomes of gastric cancer: a systematic review and meta-analysis

“…The disease often presents at an advanced stage, limiting curative treatment options and leading to high mortality rates. Therefore, identifying new prognostic biomarkers that can accurately predict disease outcomes and guide treatment decisions, is crucial (3)(4)(5)(6).…”

Current Approach and Future Directions in the Diagnosis and Prognosis of Keratinocyte Carcinomas

“…Furthermore, the paper proposes the future perspective of reversing immune evasion via epigenetic targeted therapies of even exploiting genomic events, which may prove essential in improving prognosis and survival in these patients. Chaudhury et al showed that measuring the expression of cancer stem cells in tongue SCC can yield relevant diagnostic data in terms of tumor size, histopathological grading, cancer dissemination, and mortality [ 14 ]. Additionally, in another recent paper, more attention was brought to the understanding of cellular signaling pathways involved in the carcinogenetic process of BCC.…”